Hepatitis B Dosing Chart

Share this content:
HEPATITIS B VIRUS TREATMENTS
HEPATITIS B VIRUS TREATMENTS
Generic Brand Usual Dose
adefovir dipivoxil Hepsera Adults: 10mg once daily. Renal impairment: CrCl 30−49mL/min: 10mg every 48hrs; CrCl 10−29mL/min: 10mg every 72hrs; CrCl<10mL/min (on hemodialysis): 10mg every 7 days after dialysis; (not on hemodialysis): not recommended.
Children: Not recommended.
entecavir Baraclude* Adults: ≥16yrs: Take on empty stomach. Compensated liver disease: nucleoside-naïve: 0.5mg once daily; lamivudine-refractory or known lamivudine or telbivudine resistance mutations: 1mg once daily. Decompensated liver disease: 1mg once daily. Renal impairment (nucleoside-naive): CrCl 30−49mL/min: 0.25mg once daily or 0.5mg every 48hrs; CrCl 10−29mL/min: 0.15mg once daily or 0.5mg every 72hrs; CrCl<10mL/min or on hemodialysis: 0.05mg once daily or 0.5mg every 7 days; (lamivudine-refractory or decompensated liver disease): CrCl 30−49mL/min: 0.5mg once daily or 1mg every 48hrs; CrCl 10−29mL/min: 0.3mg once daily or 1mg every 72hrs; CrCl<10mL/min or on hemodialysis: 0.1mg once daily or 1mg every 7 days. If on hemodialysis day, give after session.
Children: <16yrs: Not recommended.
interferon alfa‑2b Intron A Adults: ≥18yrs: 5 million IU daily or 10million IU IM or SC three times weekly for 16wks.
Children: <1yr: Not established. 1–17yrs: 3million IU/m2 SC three times weekly for 1wk, then increase to 6million IU/m2 (max 10 million IU) three times weekly for a total of 16–24wks.
lamivudine Epivir‑HBV Adults: 100mg once daily. Renal impairment: CrCl 30−49mL/min: 100mg for 1st dose then 50mg once daily; CrCl 15−29mL/min: 100mg for 1st dose then 25mg once daily; CrCl 5−14mL/min: 35mg for 1st dose then 15mg once daily; CrCl<5mL/min: 35mg for 1st dose then 10mg once daily.
Children: <2yrs: Not established. 2−17yrs: 3mg/kg (max 100mg) once daily.
peginterferon alfa‑2a Pegasys Adults: 180mcg once weekly for 48wks. CrCl<30mL/min or ESRD on hemodialysis: 135mcg SC once weekly; may reduce to 90mcg once weekly if severe reactions develop; if intolerance persists, discontinue.
Children: <3yrs: Not established. ≥3yrs: 180mcg/1.73m2 x BSA SC once weekly for 48wks; max dose 180mcg. Maintain pediatric dose through duration of therapy in those who turn 18yrs.
tenofovir alafenamide Vemlidy Adults: ≥18yrs: Take with food. 25mg once daily. Concomitant carbamazepine: 50mg once daily.
Children: <18yrs: Not established.
tenofovir disoproxil fumarate Viread Adults: ≥12yrs (≥35kg): 300mg once daily. Renal impairment: CrCl 30−49mL/min: 300mg every 48hrs; CrCl 10−29mL/min: 300mg every 72−96hrs; hemodialysis: 300mg every 7 days or after a total of 12hrs of dialysis; CrCl<10mL/min: not recommended.
Children: <12yrs or <35kg: Not established.
NOTES

*For doses <0.5mg, use oral solution.

(Rev. 2/2018)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs